Abstract
The management of patients with posterior uveal melanoma involves detection, examination, treatment, prognostication, counseling, and surveillance (Box 12.1). Each of these activities is advancing rapidly, thanks to technological developments as well as a better understanding of tumor biology.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2384 patients. Ophthalmology. 2012;119:1582–9.
Bove R, Char DH. Nondiagnosed uveal melanomas. Ophthalmology. 2004;111(3):554–7.
Eskelin S, Kivela T. Mode of presentation and time to treatment of uveal melanoma in Finland. Br J Ophthalmol. 2002;86(3):333–8.
Damato BE. Tumour fluorescence and tumour-associated fluorescence of choroidal melanomas. Eye (Lond). 1992;6(Pt 6):587–93.
Callejo SA, Dopierala J, Coupland SE, Damato B. Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type. Arch Ophthalmol. 2011;129(7):958–60.
Sen J, Groenewald C, Hiscott PS, Smith PA, Damato BE. Transretinal choroidal tumor biopsy with a 25-gauge vitrector. Ophthalmology. 2006;113(6):1028–31.
Feinstein EG, Marr BP, Winston CB, Abramson DH. Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma. Arch Ophthalmol. 2010;128(3):319–23.
Damato B, Heimann H. Personalized treatment of uveal melanoma. Eye (Lond). 2013;27(2):172–9.
Damato B, Lecuona K. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology. 2004;111(5):977–83.
Stannard C, Sauerwein W, Maree G, Lecuona K. Radiotherapy for ocular tumours. Eye (Lond). 2013;27(2):119–27.
Russo A, Laguardia M, Damato B. Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma. Graefes Arch Clin Exp Ophthalmol. 2012;250:1533–40.
Astrahan MA, Luxton G, Jozsef G, Kampp TD, Liggett PE, Sapozink MD, et al. An interactive treatment planning system for ophthalmic plaque radiotherapy. Int J Radiat Oncol Biol Phys. 1990;18(3):679–87.
Daftari IK, Char DH, Verhey LJ, Castro JR, Petti PL, Meecham WJ, et al. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma. Int J Radiat Oncol Biol Phys. 1997;39(5):997–1010.
Damato BE, Groenewald C, Foulds WS. Surgical resection of choroidal melanoma. In: Ryan SJ, editor. Retina. 5th ed. London: Elsevier; 2013. p. 2298–306.
Konstantinidis L, Groenewald C, Coupland SE, Damato B. Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy. Br J Ophthalmol. 2014 Feb 25. doi: 10.1136/bjophthalmol-2013-304501. [Epub ahead of print].
Schilling H, Bornfeld N, Talies S, Anastassiou G, Schuler A, Horstmann GA, et al. [Endoresection of large uveal melanomas after pretreatment by single-dose stereotactic convergence irradiation with the leksell gamma knife–first experience on 46 cases]. Klin Monbl Augenheilkd. 2006;223(6):513–20.
Journee-de Korver JG, Oosterhuis JA, Kakebeeke-Kemme HM, de Wolff-Rouendaal D. Transpupillary thermotherapy (TTT) by infrared irradiation of choroidal melanoma. Doc Ophthalmol. 1992;82(3):185–91.
Shields CL, Shields JA, Perez N, Singh AD, Cater J. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology. 2002;109(2):225–34.
Groenewald C, Konstantinidis L, Damato B. Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye (Lond). 2013;27(2):163–71.
Barbazetto IA, Lee TC, Rollins IS, Chang S, Abramson DH. Treatment of choroidal melanoma using photodynamic therapy. Am J Ophthalmol. 2003;135(6):898–9.
Wilson DJ, Klein ML. Cryotherapy as a primary treatment for choroidal melanoma. Arch Ophthalmol. 2002;120(3):400–3.
Konstantinidis L, Groenewald C, Coupland SE, Damato B. Long-term outcome of primary endoresection of choroidal melanoma. Br J Ophthalmol. 2014;98(1):82–5.
Damato B. Choroidal melanoma endoresection, dandelions and allegory-based medicine. Br J Ophthalmol. 2008;92(8):1013–4.
Bechrakis NE, Foerster MH. Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal melanomas. Int Ophthalmol Clin. 2006;46(1):95–107.
Kujala E1, Damato B, Coupland SE, Desjardins L, Bechrakis NE, Grange JD, Kivelä T. Staging of ciliary body and choroidal melanomas based on anatomic extent. J Clin Oncol. 2013;31(22):2825–31.
Damato B, Eleuteri A, Taktak AF, Coupland SE. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011;30(5):285–95.
Marshall E, Romaniuk C, Ghaneh P, Wong H, McKay M, Chopra M, et al. MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients. Br J Ophthalmol. 2013;97(2):159–63.
Eskelin S, Pyrhonen S, Summanen P, Prause JU, Kivelä T. Screening for metastatic malignant melanoma of the uvea revisited. Cancer. 1999;85(5):1151–9.
Wen JC, Sai V, Straatsma BR, McCannel TA. Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma. JAMA Ophthalmol. 2013;131(1):56–61.
Patel P, Finger PT. Whole-body 18F FDG positron emission tomography/computed tomography evaluation of patients with uveal metastasis. Am J Ophthalmol. 2012;153(4):661–8.
Strobel K, Bode B, Dummer R, Veit-Haibach P, Fischer DR, Imhof L, et al. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Eur J Nucl Med Mol Imaging. 2009;36(11):1774–82.
Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol. 2004;22(12):2438–44.
Augsburger JJ, Correa ZM, Trichopoulos N. Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival. Am J Ophthalmol. 2011;152(1):5–9 e1.
Kim IK, Lane AM, Gragoudas ES. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol. 2010;128(7):871–5.
Whitehead J, Tishkovskaya S, O’Connor J, Damato B. Devising two-stage and multistage phase II studies on systemic adjuvant therapy for uveal melanoma. Invest Ophthalmol Vis Sci. 2012;53(8):4986–9.
Ah-Fat FG, Sharma MC, Damato BE. Taping outpatient consultations: a survey of attitudes and responses of adult patients with ocular malignancy. Eye (Lond). 1998;12(Pt 5):789–91.
Damato B, Heiman H, Kalirai H, Coupland SE. Age, survival predictors, and metastatic death in patients with choroidal melanoma. Tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol. doi: 10.1001/jamaophthalmol.2014.77. Published online March 13,2014.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Damato, B. (2014). Management of Patients with Posterior Uveal Melanoma. In: Damato, B., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54255-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-54255-8_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54254-1
Online ISBN: 978-3-642-54255-8
eBook Packages: MedicineMedicine (R0)